The Type I IFN Response to Infection with Mycobacterium tuberculosis Requires ESX-1-Mediated Secretion and Contributes to Pathogenesis1
暂无分享,去创建一个
[1] S. Grinstein,et al. The ESAT‐6/CFP‐10 secretion system of Mycobacterium marinum modulates phagosome maturation , 2006, Cellular microbiology.
[2] Mark Johnson,et al. Secreted Proteins from Mycobacterium tuberculosis Gain Access to the Cytosolic MHC Class-I Antigen-Processing Pathway1 , 2006, The Journal of Immunology.
[3] H. Kornfeld,et al. Macrophage Apoptosis in Response to High Intracellular Burden of Mycobacterium tuberculosis Is Mediated by a Novel Caspase-Independent Pathway1 , 2006, The Journal of Immunology.
[4] Juan F Medrano,et al. Comparison of gene coverage of mouse oligonucleotide microarray platforms , 2006, BMC Genomics.
[5] M. Netea,et al. NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosis , 2005, PLoS pathogens.
[6] Christopher M Hickey,et al. Expression of Many Immunologically Important Genes in Mycobacterium tuberculosis-Infected Macrophages Is Independent of Both TLR2 and TLR4 but Dependent on IFN-αβ Receptor and STAT11 , 2005, The Journal of Immunology.
[7] M. Chase,et al. Mutually dependent secretion of proteins required for mycobacterial virulence. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[8] Jim Norman,et al. Structure and function of the complex formed by the tuberculosis virulence factors CFP‐10 and ESAT‐6 , 2005, The EMBO journal.
[9] G. Cheng,et al. The host type I interferon response to viral and bacterial infections , 2005, Cell Research.
[10] Ryan M. O’Connell,et al. Immune Activation of Type I IFNs by Listeria monocytogenes Occurs Independently of TLR4, TLR2, and Receptor Interacting Protein 2 but Involves TANK-Binding Kinase 11 , 2005, The Journal of Immunology.
[11] Ryan M. O’Connell,et al. Immune activation of type I IFNs by Listeria monocytogenes occurs independently of TLR4, TLR2, and receptor interacting protein 2 but involves TNFR-associated NF kappa B kinase-binding kinase 1. , 2005, Journal of Immunology.
[12] D. Sherman,et al. Tuberculous Granuloma Formation Is Enhanced by a Mycobacterium Virulence Determinant , 2004, PLoS biology.
[13] B. Finlay,et al. Evasive Maneuvers by Secreted Bacterial Proteins to Avoid Innate Immune Responses , 2004, Current Biology.
[14] D. Portnoy,et al. Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes , 2004, The Journal of experimental medicine.
[15] Ryan M. O’Connell,et al. Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection , 2004, The Journal of experimental medicine.
[16] E. Unanue,et al. Type I Interferon Sensitizes Lymphocytes to Apoptosis and Reduces Resistance to Listeria Infection , 2004, The Journal of experimental medicine.
[17] G. Cheng,et al. Differential Requirement for TANK-binding Kinase-1 in Type I Interferon Responses to Toll-like Receptor Activation and Viral Infection , 2004, The Journal of experimental medicine.
[18] S. Fortune,et al. Mycobacterium tuberculosis Inhibits Macrophage Responses to IFN-γ through Myeloid Differentiation Factor 88-Dependent and -Independent Mechanisms1 , 2004, The Journal of Immunology.
[19] D. Sherman,et al. Individual RD1‐region genes are required for export of ESAT‐6/CFP‐10 and for virulence of Mycobacterium tuberculosis , 2004, Molecular microbiology.
[20] T. Mueller,et al. Timing of IFN-β Exposure during Human Dendritic Cell Maturation and Naive Th Cell Stimulation Has Contrasting Effects on Th1 Subset Generation: A Role for IFN-β-Mediated Regulation of IL-12 Family Cytokines and IL-18 in Naive Th Cell Differentiation1 , 2003, The Journal of Immunology.
[21] S. Raghavan,et al. Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] D. Eisenberg,et al. The primary mechanism of attenuation of bacillus Calmette–Guérin is a loss of secreted lytic function required for invasion of lung interstitial tissue , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[23] Guo-Ping Zhou,et al. Triggering the Interferon Antiviral Response Through an IKK-Related Pathway , 2003, Science.
[24] T. Maniatis,et al. IKKε and TBK1 are essential components of the IRF3 signaling pathway , 2003, Nature Immunology.
[25] Michael Weiden,et al. Inhibition of Response to Alpha Interferon by Mycobacterium tuberculosis , 2003, Infection and Immunity.
[26] S. Akira,et al. The Roles of Toll-Like Receptor 9, MyD88, and DNA-Dependent Protein Kinase Catalytic Subunit in the Effects of Two Distinct CpG DNAs on Dendritic Cell Subsets1 , 2003, The Journal of Immunology.
[27] S. Akira,et al. Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling1 , 2002, The Journal of Immunology.
[28] D. Portnoy,et al. Innate recognition of bacteria by a macrophage cytosolic surveillance pathway , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] R. Modlin,et al. Control of Mycobacterium tuberculosis through mammalian Toll-like receptors. , 2002, Current opinion in immunology.
[30] S. Taki. Type I interferons and autoimmunity: lessons from the clinic and from IRF-2-deficient mice. , 2002, Cytokine & growth factor reviews.
[31] N. Boéchat,et al. Alpha/Beta Interferon Impairs the Ability of Human Macrophages To Control Growth of Mycobacterium bovis BCG , 2002, Infection and Immunity.
[32] C. Janeway,et al. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems , 2002, Nature.
[33] E. Lander,et al. Human macrophage activation programs induced by bacterial pathogens , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[34] S. Gordon,et al. Conclusive Evidence That the Major T-cell Antigens of the Mycobacterium tuberculosis Complex ESAT-6 and CFP-10 Form a Tight, 1:1 Complex and Characterization of the Structural Properties of ESAT-6, CFP-10, and the ESAT-6 CFP-10 Complex IMPLICATIONS FOR PATHOGENESIS AND VIRULENCE* , 2002 .
[35] S. Akira,et al. Lipopolysaccharide Stimulates the MyD88-Independent Pathway and Results in Activation of IFN-Regulatory Factor 3 and the Expression of a Subset of Lipopolysaccharide-Inducible Genes1 , 2001, The Journal of Immunology.
[36] O. Schneewind,et al. Protein secretion and the pathogenesis of bacterial infections. , 2001, Genes & development.
[37] Ilkka Julkunen,et al. Infection of Human Macrophages and Dendritic Cells with Mycobacterium tuberculosis Induces a Differential Cytokine Gene Expression That Modulates T Cell Response1 , 2001, The Journal of Immunology.
[38] G. Kaplan,et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-α/β , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[39] R. Modlin,et al. Activation of toll-like receptors by microbial lipoproteins. , 2001, Scandinavian journal of infectious diseases.
[40] S. Ehlers,et al. Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung , 2000, Infection and Immunity.
[41] W. Rom,et al. Differentiation of Monocytes to Macrophages Switches the Mycobacterium tuberculosis Effect on HIV-1 Replication from Stimulation to Inhibition: Modulation of Interferon Response and CCAAT/Enhancer Binding Protein β Expression1 , 2000, The Journal of Immunology.
[42] D. Baltimore,et al. NF‐κB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK‐related kinase , 1999, The EMBO journal.
[43] L. Ting,et al. Mycobacterium tuberculosis inhibits IFN-gamma transcriptional responses without inhibiting activation of STAT1. , 1999, Journal of immunology.
[44] D. Golenbock,et al. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. , 1999, Journal of immunology.
[45] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Stark,et al. How cells respond to interferons. , 1998, Annual review of biochemistry.
[47] P. Brown,et al. Exploring the metabolic and genetic control of gene expression on a genomic scale. , 1997, Science.
[48] J. Flynn,et al. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection , 1993, The Journal of experimental medicine.